临床药师在医院获得性肺炎合并MRSA血流感染患者诊治体会中的团队价值  

Team values of clinical pharmacists in the treatment of one case of hospital-acquired pneumonia coinfected with MRSA bloodstream infection

作　　者：王宏虹 王实慧 冯瑾[3] 徐红冰[4] 

机构地区：[1]柳州市妇幼保健院,广西柳州545001 [2]江西省萍乡市人民医院,江西萍乡337000 [3]第二军医大学附属长征医院,上海200433 [4]上海交通大学附属第一人民医院,上海200080

出　　处：《实用药物与临床》2015年第3期319-322,共4页Practical Pharmacy and Clinical Remedies

摘　　要：目的通过参与医院获得性肺炎合并MRSA血流感染患者的药物治疗,探讨临床药师在治疗团队中的价值。方法根据患者肺部感染特点、基础疾病的影响、MRSA感染治疗原则及推荐治疗药物的特点,协助临床医生优化抗感染方案,提供药学服务。结果临床药师参与制定抗感染治疗方案后,患者症状好转,有效降低了药物不良反应的危害。结论临床药师参与治疗团队有利于促进临床合理用药、提高药物治疗效果。Objective To evaluate the clinical value of clinical pharmacists in the clinical treatment team through participating in the treatment of one case of hospital-acquired pneumonia coinfected with bloodstream infection.Methods According to the characteristics of lung infection,the effect of elementary disease,the principles of the MRSA infection therapy and characteristics of recommended drugs,clinical pharmacists assisted physicians in optimization of anti-infective therapy regimen and provided pharmaceutical care.Results After clinical pharmacists participated in instituting anti-infective therapeutic project,the symptoms and signs of patients were improved obviously and the adverse drug reactions reduced.Conclusion Clinical pharmacists participate in the clinical drug treatment team can promote rational use of drugs and enhance the pharmacotherapeutic efficacy.

关 键 词：医院获得性肺炎 耐甲氧西林金黄色葡萄球菌 血流感染 临床药师 药学监护 

分 类 号：R563.1[医药卫生—呼吸系统]